| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
37,536 |
28,510 |
$1.52M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,019 |
1,343 |
$213K |
| 92134 |
|
5,020 |
3,782 |
$128K |
| 92002 |
|
3,930 |
3,361 |
$123K |
| 92083 |
|
2,515 |
2,047 |
$73K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
686 |
495 |
$68K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
933 |
784 |
$46K |
| 92133 |
|
1,768 |
1,456 |
$33K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
327 |
276 |
$25K |
| 92250 |
|
1,046 |
874 |
$21K |
| 92201 |
|
861 |
609 |
$17K |
| 76519 |
|
289 |
230 |
$17K |
| 92226 |
|
1,569 |
1,300 |
$16K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
230 |
164 |
$14K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
346 |
257 |
$14K |
| J9035 |
Injection, bevacizumab, 10 mg |
425 |
317 |
$10K |
| 92015 |
Determination of refractive state |
928 |
784 |
$8K |
| 99233 |
Prolong inpt eval add15 m |
110 |
54 |
$8K |
| 99223 |
Prolong inpt eval add15 m |
35 |
31 |
$6K |
| 92225 |
|
405 |
346 |
$5K |
| 92202 |
|
246 |
204 |
$2K |
| 99070 |
|
166 |
138 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26 |
25 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
45 |
38 |
$2K |
| 99241 |
|
51 |
40 |
$1K |
| 76514 |
|
50 |
32 |
$186.78 |
| 92020 |
|
23 |
14 |
$142.28 |